Epidemiological Monitoring of Tuberculosis Among Military Personnel in Ukraine: the Impact of the War and Key Priorities for the Development of the National Tuberculosis Prevention Program
DOI:
https://doi.org/10.15407/scine21.03.099Keywords:
tuberculosis, multidrug-resistant (MDR) tuberculosis, screening, military servants, sanitary and epidemiological surveillance, prevention.Abstract
Introduction. The war in Ukraine has exacerbated the humanitarian crisis and severely damaged the healthcare infrastructure, which had already been weakened in recent years by the COVID-19 pandemic, creating a new threat to the fight against tuberculosis. The incidence of tuberculosis within the Armed Forces has increased, mirroring the broader trends of rising tuberculosis rates across Ukraine.
Problem Statement. In light of the difficult epidemic situation with tuberculosis globally, in Ukraine, and within its Armed Forces, the issues of diagnosis, treatment, and prevention of tuberculosis have become extremely urgent.
Purpose. The aim of this study is to analyze the specific developments in tuberculosis infection among military personnel and the need for the implementation of innovative measures for its prevention, early diagnosis, and treatment.
Materials and Methods. The materials for this study included reports on tuberculosis incidence from 2017 to 2023 among servicemen within the administrative territorial zones of responsibility, as determined by the Regional Sanitary and Epidemiological Department of the Command of the Medical Forces of the Armed Forces of Ukraine. Analytical and epidemiological methods, as well as mathematical modeling techniques, have been applied.
Results. The relationship between the increase in tuberculosis incidence among the servicemen of the Armed Forces of Ukraine and the armed aggression by the Russian Federation was highlighted. From 2021 to 2023, a sharp increase in military personnel illness rates was observed, rising from 0.2‰ to 1.82‰. The morbidity ratio in 2023 compared to 2022 was 170.09%. The predicted incidence rate for 2024 is 1.42‰ (unfavorable).
Conclusions. Ensuring effective treatment for tuberculosis, particularly multi-drug resistant forms, through the use of innovative early diagnosis methods, is one of the primary objectives for domestic medicine. Additionally, identifying cofactors contributing to tuberculosis development remains a crucial task.
Downloads
References
Kia, P., Ruman, U., Pratiwi, A. R., Hussein, M. Z. (2023). Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis. International Journal of Nanomedicine, 18, 1159—1191. https://doi.org/10.2147/IJN.S364634
World Health Organization (WHO) (2021). Global Tuberculosis Report 2021. Geneva, WHO, 2021. URL: apps.who. int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf/ (Last accessed: 23.07.2024).
Kiazyk, S., Ball, T. (2017). Latent tuberculosis infection: an overview. Can. Commun. Dis. Rep., 43, 62—66. https://doi.org/10.14745/ccdr.v43i34a01
World Heath Organization (WHO) (2022). Rapid Communication: Key Changes to the Treatment of Drug-Resistant Tuberculosis. World Heath Organization; 2022. URL: https://www.who.int/publications/i/item/WHO-UCN-TB-2022-2 (Last accessed: 23.07.2024).
World Health Organization. ( 2015) . Global tuberculosis report 2015, 20th, Ed. World Health Organization. URL: https://iris.who.int/handle/10665/191102 (Last accessed: 23.07.2024).
Wilczek, N. A, Brzyska, A., Bogucka, J., Sielwanowska, W. E., Żybowska, M., Piecewicz-Szczęsna, H., Smoleń, A. (2023). The Impact of the War in Ukraine on the Epidemiological Situation of Tuberculosis in Europe. Journal of Clinical Medicine, 12(20), 6554. https://doi.org/10.3390/jcm12206554
Merker, M., Nikolaevskaya, E., Kohl, T. A., Molina-Moya, B., Pavlovska, O., Brannberg, P., …, Niemann, S. (2020). Multidrug- and extensively drug-resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015. Emerg. Infect. Dis., 26(3), 481—490. https://doi.org/10.3201/eid2603.190525
Tuberculosis, analytical and statistical guide for 2022 in Ukraine. (2023). State University «Public Health Center of the Ministry of Health of Ukraine». Kyiv. URL: https://phc.org.ua/sites/default/files/users/user90/TB_surveillance_statistical-information_2022_dovidnyk.pdf (Last accessed: 23.07.2024) [in Ukrainian].
Khomenko, I. P., Lurin. I. A., Tsymbalyuk, V. I. (2020). Medical support of the Armed Forces of Ukraine. Kyiv [in Ukrainian].
Toman’s tuberculosis. Case detection, treatment, and monitoring — question and answers (2004) (Ed. T. Frieden). 2nd ed. World Health Organization, Geneve.
Feshchenko, Yu. I., Petrenko, V. M., Cherenko, S. O., Bialik, Y. B., Lytvynenko, N. A., Tsygankova, L. M., ..., Davydenko, V. V. (2007). New cases of pulmonary tuberculosis: results of treatment, causes of insufficient effectiveness. Journal of the Academy of Medical Sciences of Ukraine, 13(3), 567—578 [in Ukrainian].
Feshchenko, Yu. I., Melnyk, V. M., Opanasenko, M. S. (2019). Ineffective treatment of patients with pulmonary tuberculosis and its prevention. Kyiv [in Ukrainian].
Spasenko, О., Kholodna, L. (2006). Characteristic features of biological properties of tuberculosis causative agent. Visnyk of the National Academy of Sciences of Ukraine, 8, 13—16. URL: http://dspace.nbuv.gov.ua/handle/123456789/1954 (Last accessed: 23.07.2024) [in Ukrainian]. https://doi.org/10.15407/ugz2024.02.013
State strategy for the development of the system of anti-tuberculosis medical care for the population [Order N 1414-p, Approved by the Decree of the Cabinet of Ministers of Ukraine of November 27, 2019 No. 1414-р.] (2020). Tuberculosis, lung diseases, HIV infection, 1(40), 18—24 [in Ukrainian].
Recommendations “Strategic directions for the implementation of measures to improve tracking, examination and preventive treatment of contact persons with an index case of tuberculosis”/ State University “Public Health Center of the Ministry of Health of Ukraine”. Kyiv, 2023 [in Ukrainian].
Terleeva, Ya. S., Goncharova, M. I., Kuzin, I. V., Sereda, Yu. V. (2020). Barriers to tuberculosis treatment in Ukraine. Tuber culosis, lung diseases, HIV infection, 3(42), 7—16. https://doi.org/10.30978/TB2020-3-7 [in Ukrainian].
Pareek, M., Greenaway, C., Noori, T., Munoz, J., Zenner, D. (2016). The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med., 14, 48. https://doi.org/10.1186/s12916-016-0595-5
Dahl, V. N., Tiberi, S., Goletti, D., Wejse, C. (2022). Armed conflict and human displacement may lead to an increase in the burden of tuberculosis in Europe. Int. J. Infect. Dis., 124, 104—106. https://doi.org/10.1016/j.ijid.2022.03.040
Fatyga, E., Dzięgielewska-Gęsiak, S., Muc-Wierzgoń, M. (2022). Organization of Medical Assistance in Poland for Ukrainian Citizens during the Russia-Ukraine War. Front. Public Health, 10, 904588. https://doi.org/10.3389/fpubh.2022.904588
Roberts, L. (2022). Surge of HIV, tuberculosis and COVID feared amid war in Ukraine. Nature, 603, 557—558. https://doi.org/10.1038/d41586-022-00748-6
Hauer, B., Kröger, S., Haas, W., Brodhun, B. (2023). Tuberculosis in times of war and crisis: Epidemiological trends and characteristics of patients born in Ukraine, Germany, 2022. EuroSurveillance, 28(24), 2300284. https://doi.org/10.2807/1560-7917.ES.2023.28.24.2300284
Essar, M. Y., Rezayee, K. J., Ahmad, S., Kamal, M.A., Nasery, R., Danishmand, T.J., …, Nemat, A. (2022). Knowledge, Attitude, and Practices Toward Tuberculosis Among Hospital Outpatients in Kabul, Afghanistan. Front Public Health, 10, 933005. https://doi.org/10.3389/fpubh.2022.933005
Mancuso, J. D., Aaron, C. L. (2013). Tuberculosis trends in the U.S. Armed Forces, active component, 1998—2012. MSMR, 20(5), 4—8. PMID: 23731007.
Mancuso, J. D. (2017). Tuberculosis Screening and Control in the US Military in War and Peace. Am. J. Public. Health, 107(1), 60—67. https://doi.org/10.2105/AJPH.2016.303502
Dzhus, M., Golovach, I. (2022). Impact of Ukrainian-Russian War on Healthcare and Humanitarian Crisis. Disaster Med. Public Health Prep., 17, e340. https://doi.org/10.1017/dmp.2022.265
Luke, E., Swafford, K., Shirazi, G., Venketaraman, V. (2022). TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection. Front Biosci. (Schol Ed)., 14(1), 6. https://doi.org/10.31083/j.fbs1401006
Kimbrough, W., Saliba, V., Dahab, M., Haskew, C., Checchi, F. (2012). The burden of tuberculosis in crisis-affected populations: a systematic review. Lancet Infect. Dis., 12, 950—965. https://doi.org/10.1016/S1473-3099(12)70225-6
Qi, M., Zhang, L., Gan, W., Xu, Y., Wei, J., Fu, X., Li, X. (2023). The Imaging Features and Diagnostic Value of Computerised Tomography in Seminal Duct Tuberculosis. Journal of Multidisciplinary Healthcare, 16, 1395—1402. https://doi.org/10.2147/JMDH.S401660
WHO G. Global tuberculosis report 2020. (2020). Glob. Tuberc. Rep., S7—S12.
McKee, M., Nagyova, I. (2022). When the guns fall silent… Priorities for health in post-war Ukraine. European Journal of Public Health, 32(4), 517—518. https://doi.org/10.1093/eurpub/ckac090
Verma, N., Arora, V., Awasthi, R., Chan, Y., Jha, N. K., Thapa, K., ..., Dua, K. (2022). Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis. Journal of Drug Delivery Science and Technology, 75, 103690. https://doi.org/10.1016/j.jddst.2022.103690
Steingart, K. R., Ng, V., Henry, M., Hopewell, P. C., Ramsay, A., Cunningham, J., …, Pai, M. (2006). Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: A systematic review. Lancet Infect. Dis., 6, 664—674. https://doi.org/10.1016/S1473-3099(06)70602-8
Kumar, M., Virmani, T., Kumar, G., Deshmukh, R., Sharma, A., Duarte, S., …, Fonte, P. (2023). Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies. Pharmaceuticals, 16(10), 1360. https://doi.org/10.3390/ph16101360
Hsu, D., Irfan, M., Jabeen, K., Iqbal, N., Hasan, R., Migliori, G. B., …, Tiberi, S. (2020). Post Tuberculosis Treatment Infectious Complications. Int. J. Infect. Dis., 92, 41—45. https://doi.org/10.1016/j.ijid.2020.02.032
Kamphee, H., Chaiprasert, A., Prammananan, T., Wiriyachaiporn, N., Kanchanatavee, A., Dharakul, T. (2015). Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay. PLoS One, 10(9), e0137791. https://doi.org/10.1371/journal.pone.0137791
Orenstein, E. W., Basu, S., Shah, N. S., Andrews, J. R., Friedland, G. H., Moll, A. P., …, Galvani, A. P. (2009). Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect. Dis., 9(3), 153−161. https://doi.org/10.1016/S1473-3099(09)70041-6
Protocol of a study in the field of anti-tuberculosis: causes of late detection of multidrug-resistant tuberculosis (MDR-TB) and planning interventions to reduce the spread of generalized forms of tuberculosis. (2018). The Center of social expertises named after Yuri Saenko. Kyiv [in Ukrainian].
Mason, P. H., Oni, T., van Herpen, M. M., Coussens, A. K. (2016). Tuberculosis prevention must integrate technological and basic care innovation. European Respiratory Journal, 48, 1529−1531. https://doi.org/10.1183/13993003.01449-2016
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Copyright Notice Authors published in the journal “Science and Innovation” agree to the following conditions: Authors retain copyright and grant the journal the right of first publication. Authors may enter into separate, additional contractual agreements for non-exclusive distribution of the version of their work (article) published in the journal “Science and Innovation” (for example, place it in an institutional repository or publish in their book), while confirming its initial publication in the journal “Science and innovation.” Authors are allowed to place their work on the Internet (for example, in institutional repositories or on their website).
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
